Brinker Capital Investments, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brinker Capital Investments, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2022$777,950
-0.4%
10,606
+3.2%
0.02%
-6.2%
Q3 2022$781,000
+19.4%
10,273
+9.2%
0.02%
+33.3%
Q2 2022$654,000
-20.3%
9,405
-5.1%
0.01%
-7.7%
Q1 2022$821,000
-2.0%
9,912
-11.2%
0.01%
+8.3%
Q4 2021$838,000
-67.4%
11,160
-3.6%
0.01%
-70.7%
Q3 2021$2,567,0000.0%11,5740.0%0.04%
+20.6%
Q2 2021$2,567,000
+85.1%
11,574
+10.3%
0.03%
+61.9%
Q1 2021$1,387,000
-61.6%
10,490
-49.8%
0.02%
-62.5%
Q4 2020$3,615,000
+203.3%
20,892
+95.1%
0.06%
+180.0%
Q3 2020$1,192,000
+23740.0%
10,706
+19725.9%
0.02%
Q4 2019$5,000540.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders